Comparison of micro-radiofrequency therapy and tolterodine for the treatment of newly diagnosed overactive bladder: A retrospective cohort study
PurposeThis study aimed to retrospectively compare the efficacy and safety of micro-radiofrequency (RF) therapy through the urethra vs. oral tolterodine tartrate in the treatment of newly diagnosed overactive bladder (OAB).Materials and methodsIn this study, 46 patients who were newly diagnosed with...
| Main Authors: | , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2023-03-01
|
| Series: | Frontiers in Neuroscience |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fnins.2023.1120843/full |
| _version_ | 1797867282187157504 |
|---|---|
| author | Min Tang Jin Liu Chesong Zhao Chengming Wang Qian Zhang Mulong Du Xiaoxin Meng Pu Li |
| author_facet | Min Tang Jin Liu Chesong Zhao Chengming Wang Qian Zhang Mulong Du Xiaoxin Meng Pu Li |
| author_sort | Min Tang |
| collection | DOAJ |
| description | PurposeThis study aimed to retrospectively compare the efficacy and safety of micro-radiofrequency (RF) therapy through the urethra vs. oral tolterodine tartrate in the treatment of newly diagnosed overactive bladder (OAB).Materials and methodsIn this study, 46 patients who were newly diagnosed with moderate-to-severe OAB were included; 23 of them underwent the micro-RF treatment procedure, and the other 23 patients took tolterodine. Bladder diaries were recorded 3 days before treatment and during the follow-up period on 1, 3, and 7 weeks after micro-RF therapy or oral tolterodine. Micturition parameters including daily voiding times, daily urge urinary incontinence (UI) episodes, daily urgency episodes, mean volume per micturition, post-void residual volume (PVR), maximum urine flow rate (Qmax), overactive bladder symptom score (OABSS), and quality of life (QoL) score were analyzed.ResultsAll 46 patients underwent either micro-RF or oral tolterodine treatment, as well as a complete follow-up. The incidence of adverse events in the micro-RF group was 8.7% (2/23), and that in the tolterodine group was 43.5% (10/23). The following two adverse events happened in the micro-RF group: an injury to the urethra during catheterization in a man and a urinary tract infection in a woman, both of which were relieved or disappeared after day 3. The adverse effects in the tolterodine group were mainly dry mouth (4/23), dysuria (5/23), and constipation (8/23), but none of the patients withdrew from the drug therapy. Compared to pre-therapy, all parameters of both groups, including daily voiding times, daily urgency episodes, mean volume per micturition, OABSS, and QoL score, demonstrated significant improvements during follow-up in 7 weeks after therapy, except for daily UI episodes in the tolterodine group, while the above parameters showed bigger improvements in the micro-RF group than in the tolterodine group. Besides, the general treatment efficacy of micro-RF was 73.9% (17/23), which was significantly better than tolterodine (10/23, 43.5%), and the difference was 30.4% [95% CI: 3.4–57.5%, p = 0.036].ConclusionIn this retrospective study, we found that micro-RF therapy is safe and more effective than oral tolterodine for newly diagnosed moderate-to-severe OAB in a short-term follow-up. Stronger evidence would be provided through a well-designed, prospective, randomized controlled trial. |
| first_indexed | 2024-04-09T23:37:48Z |
| format | Article |
| id | doaj.art-ee2465ff78474985a20567bb792448cc |
| institution | Directory Open Access Journal |
| issn | 1662-453X |
| language | English |
| last_indexed | 2024-04-09T23:37:48Z |
| publishDate | 2023-03-01 |
| publisher | Frontiers Media S.A. |
| record_format | Article |
| series | Frontiers in Neuroscience |
| spelling | doaj.art-ee2465ff78474985a20567bb792448cc2023-03-20T05:00:44ZengFrontiers Media S.A.Frontiers in Neuroscience1662-453X2023-03-011710.3389/fnins.2023.11208431120843Comparison of micro-radiofrequency therapy and tolterodine for the treatment of newly diagnosed overactive bladder: A retrospective cohort studyMin Tang0Jin Liu1Chesong Zhao2Chengming Wang3Qian Zhang4Mulong Du5Xiaoxin Meng6Pu Li7Department of Urology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, ChinaClinical Medicine Research Institution, The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, ChinaDepartment of Urology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, ChinaDepartment of Urology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, ChinaDepartment of Urology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, ChinaDepartment of Biostatistics, Center for Global Health, School of Public Health, Nanjing Medical University, Nanjing, Jiangsu, ChinaDepartment of Urology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, ChinaDepartment of Urology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, ChinaPurposeThis study aimed to retrospectively compare the efficacy and safety of micro-radiofrequency (RF) therapy through the urethra vs. oral tolterodine tartrate in the treatment of newly diagnosed overactive bladder (OAB).Materials and methodsIn this study, 46 patients who were newly diagnosed with moderate-to-severe OAB were included; 23 of them underwent the micro-RF treatment procedure, and the other 23 patients took tolterodine. Bladder diaries were recorded 3 days before treatment and during the follow-up period on 1, 3, and 7 weeks after micro-RF therapy or oral tolterodine. Micturition parameters including daily voiding times, daily urge urinary incontinence (UI) episodes, daily urgency episodes, mean volume per micturition, post-void residual volume (PVR), maximum urine flow rate (Qmax), overactive bladder symptom score (OABSS), and quality of life (QoL) score were analyzed.ResultsAll 46 patients underwent either micro-RF or oral tolterodine treatment, as well as a complete follow-up. The incidence of adverse events in the micro-RF group was 8.7% (2/23), and that in the tolterodine group was 43.5% (10/23). The following two adverse events happened in the micro-RF group: an injury to the urethra during catheterization in a man and a urinary tract infection in a woman, both of which were relieved or disappeared after day 3. The adverse effects in the tolterodine group were mainly dry mouth (4/23), dysuria (5/23), and constipation (8/23), but none of the patients withdrew from the drug therapy. Compared to pre-therapy, all parameters of both groups, including daily voiding times, daily urgency episodes, mean volume per micturition, OABSS, and QoL score, demonstrated significant improvements during follow-up in 7 weeks after therapy, except for daily UI episodes in the tolterodine group, while the above parameters showed bigger improvements in the micro-RF group than in the tolterodine group. Besides, the general treatment efficacy of micro-RF was 73.9% (17/23), which was significantly better than tolterodine (10/23, 43.5%), and the difference was 30.4% [95% CI: 3.4–57.5%, p = 0.036].ConclusionIn this retrospective study, we found that micro-RF therapy is safe and more effective than oral tolterodine for newly diagnosed moderate-to-severe OAB in a short-term follow-up. Stronger evidence would be provided through a well-designed, prospective, randomized controlled trial.https://www.frontiersin.org/articles/10.3389/fnins.2023.1120843/fullmicro radiofrequency therapytolterodineoveractive bladderfrequent urinationurgent urination |
| spellingShingle | Min Tang Jin Liu Chesong Zhao Chengming Wang Qian Zhang Mulong Du Xiaoxin Meng Pu Li Comparison of micro-radiofrequency therapy and tolterodine for the treatment of newly diagnosed overactive bladder: A retrospective cohort study Frontiers in Neuroscience micro radiofrequency therapy tolterodine overactive bladder frequent urination urgent urination |
| title | Comparison of micro-radiofrequency therapy and tolterodine for the treatment of newly diagnosed overactive bladder: A retrospective cohort study |
| title_full | Comparison of micro-radiofrequency therapy and tolterodine for the treatment of newly diagnosed overactive bladder: A retrospective cohort study |
| title_fullStr | Comparison of micro-radiofrequency therapy and tolterodine for the treatment of newly diagnosed overactive bladder: A retrospective cohort study |
| title_full_unstemmed | Comparison of micro-radiofrequency therapy and tolterodine for the treatment of newly diagnosed overactive bladder: A retrospective cohort study |
| title_short | Comparison of micro-radiofrequency therapy and tolterodine for the treatment of newly diagnosed overactive bladder: A retrospective cohort study |
| title_sort | comparison of micro radiofrequency therapy and tolterodine for the treatment of newly diagnosed overactive bladder a retrospective cohort study |
| topic | micro radiofrequency therapy tolterodine overactive bladder frequent urination urgent urination |
| url | https://www.frontiersin.org/articles/10.3389/fnins.2023.1120843/full |
| work_keys_str_mv | AT mintang comparisonofmicroradiofrequencytherapyandtolterodineforthetreatmentofnewlydiagnosedoveractivebladderaretrospectivecohortstudy AT jinliu comparisonofmicroradiofrequencytherapyandtolterodineforthetreatmentofnewlydiagnosedoveractivebladderaretrospectivecohortstudy AT chesongzhao comparisonofmicroradiofrequencytherapyandtolterodineforthetreatmentofnewlydiagnosedoveractivebladderaretrospectivecohortstudy AT chengmingwang comparisonofmicroradiofrequencytherapyandtolterodineforthetreatmentofnewlydiagnosedoveractivebladderaretrospectivecohortstudy AT qianzhang comparisonofmicroradiofrequencytherapyandtolterodineforthetreatmentofnewlydiagnosedoveractivebladderaretrospectivecohortstudy AT mulongdu comparisonofmicroradiofrequencytherapyandtolterodineforthetreatmentofnewlydiagnosedoveractivebladderaretrospectivecohortstudy AT xiaoxinmeng comparisonofmicroradiofrequencytherapyandtolterodineforthetreatmentofnewlydiagnosedoveractivebladderaretrospectivecohortstudy AT puli comparisonofmicroradiofrequencytherapyandtolterodineforthetreatmentofnewlydiagnosedoveractivebladderaretrospectivecohortstudy |